EAM
VERA icon

Exome Asset Management’s Vera Therapeutics VERA Stock Holding History

Exome Asset Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.17M Sell
97,276
-17,715
-15% -$660K 2.58% 11
2026
Q1 		$4.63M Sell
114,991
-9,400
-8% -$405K 2.39% 11
2025
Q4 		$6.3M Sell
124,391
-31,681
-20% -$1.13M 3.01% 8
2025
Q3 		$4.54M Buy
156,072
+79,372
+103% +$1.84M 2.75% 9
2025
Q2 		$1.81M Buy
+76,700
New +$1.72M 1.34% 34

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Exome Asset Management's VERA Position: Q2 2026 in Review

Exome Asset Management reduced its Vera Therapeutics (VERA) stake by 15% in Q2 2026, selling an estimated $660K and leaving 97,276 shares worth $4.17M. The position accounts for 2.58% of the portfolio, ranked #11.

Exome Asset Management first reported a position in VERA in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.3M in Q4 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Exome Asset Management held 97,276 shares of Vera Therapeutics worth $4.17M as of Q2 2026.
  • Exome Asset Management sold 17,715 Vera Therapeutics shares in Q2 2026, an estimated $660K.
  • Vera Therapeutics made up 2.58% of Exome Asset Management's portfolio in Q2 2026, its #11 holding.
  • Exome Asset Management first reported a position in Vera Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Exome Asset Management's Vera Therapeutics position peaked at $6.3M in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Exome Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.